| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.022 | 0.9 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0024 | 0.9 |